Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report) – Analysts at Zacks Research dropped their Q3 2025 EPS estimates for shares of Acadia Healthcare in a research report issued on Wednesday, December 18th. Zacks Research analyst Z. Masood now forecasts that the company will earn $0.97 per share for the quarter, down from their prior estimate of $0.98. The consensus estimate for Acadia Healthcare’s current full-year earnings is $3.38 per share.
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last released its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. The firm had revenue of $815.60 million for the quarter, compared to analysts’ expectations of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The business’s quarterly revenue was up 8.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.91 earnings per share.
Read Our Latest Report on ACHC
Acadia Healthcare Stock Performance
NASDAQ:ACHC opened at $37.90 on Friday. The stock has a market cap of $3.52 billion, a P/E ratio of 12.43, a PEG ratio of 1.77 and a beta of 1.29. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. The business’s 50-day moving average price is $43.80 and its two-hundred day moving average price is $60.87. Acadia Healthcare has a twelve month low of $36.50 and a twelve month high of $87.77.
Institutional Investors Weigh In On Acadia Healthcare
Large investors have recently made changes to their positions in the company. Blue Trust Inc. raised its holdings in Acadia Healthcare by 86.1% during the 2nd quarter. Blue Trust Inc. now owns 536 shares of the company’s stock valued at $36,000 after buying an additional 248 shares during the period. Fifth Third Wealth Advisors LLC bought a new stake in shares of Acadia Healthcare in the 2nd quarter worth about $206,000. Bank of New York Mellon Corp grew its holdings in Acadia Healthcare by 6.6% during the 2nd quarter. Bank of New York Mellon Corp now owns 1,249,369 shares of the company’s stock valued at $84,382,000 after purchasing an additional 77,509 shares during the last quarter. Verdence Capital Advisors LLC bought a new position in Acadia Healthcare during the 2nd quarter valued at about $237,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in Acadia Healthcare by 46.0% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 27,483 shares of the company’s stock worth $1,856,000 after purchasing an additional 8,657 shares during the last quarter.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Featured Stories
- Five stocks we like better than Acadia Healthcare
- 3 Warren Buffett Stocks to Buy Now
- Oil Titans Face Off: Exxon Mobil or Chevron for 2025 Gains?
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Mining Stocks Back in the Spotlight: 3 Key Names to Watch
- Low PE Growth Stocks: Unlocking Investment Opportunities
- MarketBeat Week in Review – 12/16 – 12/20
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.